Cite
HARVARD Citation
Hamai, K. et al. (2020). First‐line immune checkpoint therapy in metastatic squamous cell lung cancer harboring both EGFR mutation and high expression of PD‐L1: A case report. Thoracic cancer. 11 (6), pp. 1716-1719. [Online].